Skip to main content
logo
Captor Therapeutics Spolka Akcyjna (WSE:CTX)
Poland flag Poland · Delayed Price · Currency is PLN
69.80
0.00 (0.00%)
Sep 25, 2026, 11:10 AM CET

WSE:CTX Revenue

Captor Therapeutics Spolka Akcyjna had revenue of 1.63M PLN in the quarter ending June 30, 2026, a decrease of -18.71%. This brings the company's revenue in the last twelve months to 2.01M, down -81.93% year-over-year. In the year 2025, Captor Therapeutics Spolka Akcyjna had annual revenue of 4.66M, down -70.55%.

Revenue (ttm)
2.01M
Revenue Growth
-81.93%
P/S Ratio
221.07
Revenue / Employee
n/a
Employees
82
Market Cap
443.47M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.66M-11.17M-70.55%
Dec 31, 202415.83M2.62M19.88%
Dec 31, 202313.20M4.04M44.15%
Dec 31, 20229.16M5.17M129.75%
Dec 31, 20213.99M--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 201816.00K-458.00K-96.62%
Dec 31, 2017474.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
BIOTON257.23M
Ryvu Therapeutics83.94M
Synthaverse42.19M
Mabion17.61M
Molecure6.52M
Urteste2.50M
Pharmena1.46M
Poltreg240.00K
Revenue Rankings

Captor Therapeutics Spolka Akcyjna News

More News